- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03109613
PEEP and V/Q Mismatch in Premature Infants
November 16, 2020 updated by: Children's Hospital of Philadelphia
Selecting PEEP in Ventilated Premature Infants by Reducing Ventilation/Perfusion Mismatch: a Pilot Feasibility Study
Positive end-expiratory pressure (PEEP) is used in premature infants receiving mechanical ventilation to maintain lungs open and facilitate gas exchange.
When ventilation/perfusion mismatch is present, areas of the lung that are open for gas exchange do not match up with areas of the lung that are receiving blood for gas exchange.
This study measures the feasibility of enrolling and completing study maneuvers in premature infants for a prospective study measuring the responsiveness of V/Q mismatch to changes in the amount (or level) of PEEP.
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
12
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Delaware
-
Newark, Delaware, United States, 19713
- Christiana Care Health System
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- The Children's Hospital of Philadelphia
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 second to 4 weeks (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Preterm birth before 32 weeks gestational age by best obstetric estimate, determined by the clinical obstetric team during antepartum admission
- Birth weight less than 1500 grams, as measured by the clinical team at neonatal admission.
- Presence of endotracheal intubation and invasive mechanical ventilation
- Less than or equal to 28 days chronologic age
- Supplemental oxygen requirement, with a fraction of inspired oxygen (FiO2) equal to or greater than 0.25 as documented on the bedside infant flow sheet.
Exclusion Criteria:
- Congenital anomalies, as determined by the clinical supervising physician
- Current of prior air leak syndrome, as determined by the clinical supervising physician.
- Non-English speaking parents
- Non-viable birth, as determined by the clinical supervising physician
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Positive end-expiratory pressure (PEEP) level changes
Sequential changes in PEEP level within range of 4-8 cm H2O followed by measurement of V/Q mismatch at each level.
|
level changes as per arm description
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility assessed by rate of successfully study enrollment and completion
Time Frame: Full enrollment (12 subjects)
|
Rate of successfully study enrollment and completion
|
Full enrollment (12 subjects)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ventilation/perfusion mismatch
Time Frame: 10-20 minutes following each PEEP level change
|
Measured by non-invasive computerized technique based of curvilinear characteristics generated by a best-fit curve connection the fractional inspired oxygen and corresponding peripheral oxygen saturation pairs
|
10-20 minutes following each PEEP level change
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Haresh Kirpalani, BM, MSc, University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 11, 2016
Primary Completion (ACTUAL)
August 8, 2018
Study Completion (ACTUAL)
August 8, 2018
Study Registration Dates
First Submitted
April 6, 2017
First Submitted That Met QC Criteria
April 11, 2017
First Posted (ACTUAL)
April 12, 2017
Study Record Updates
Last Update Posted (ACTUAL)
November 17, 2020
Last Update Submitted That Met QC Criteria
November 16, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-013702
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant, Premature, Diseases
-
University of MiamiPontificia Universidad Catolica de ChileTerminated
-
Chang Gung Memorial HospitalNot yet recruitingParent-Child Relations | Premature Infant Disease | Premature; Infant, Light-for-dates
-
Aydin Adnan Menderes UniversityCompletedNursing Caries | Infant Development | Premature Infant Disease | Patient ComfortTurkey
-
University of VirginiaRecruitingDevelopment, Infant | Premature Infant DiseaseUnited States
-
The First Hospital of Jilin UniversityNot yet recruitingExtremely Premature Infant
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedInfant, Premature | Infant, Newborn
-
Istituto Giannina GasliniEubrainTerminated
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedSepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
Sun Yat-sen UniversityRecruitingPremature Infant DiseaseChina
Clinical Trials on Positive end-expiratory pressure (PEEP)
-
Bozyaka Training and Research HospitalCompletedRegional Cerebral Oxygen SaturationTurkey
-
Tanta UniversityRecruitingLaparoscopic Bariatric Surgery | Postoperative Atelectasis | Positive End-expiratory Pressure | Hemodynamic VariableEgypt
-
Brugmann University HospitalCompleted
-
Seoul National University HospitalUnknown
-
Johannes Gutenberg University MainzCompletedRespiratory InsufficiencyGermany
-
Capital Medical UniversityCompleted
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingVentilator-Induced Lung Injury | Sepsis Syndrome | Mechanical Ventilation ComplicationUnited States
-
Vastra Gotaland RegionGöteborg University; Sahlgrenska University HospitalNot yet recruitingPneumonia | Respiratory Failure | Respiratory Insufficiency | ARDS (Acute Respiratory Distress Syndrome)Sweden
-
Jiaxiang ChenEnrolling by invitation
-
University of VersaillesCompletedTracheostomy | Mechanical VentilationFrance